FDA Approves New Drug for Treating Most Common Type of Lung Cancer, Based on Broad Institute Research The Broad Institute, a research collaboration between Harvard and MIT, is a center for biomedical ...

Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype. Stage 3a lung cancer is often treated with surgery and medicines before or after surgery. Stage 3b and 3c ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...

Experimental drug, divarasib, showed meaningful improvements in both patients’ overall survival and the time they survived ...

Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature ...

Most lung cancers aren’t diagnosed until you’re older. In fact, on average, lung cancer shows up around the age of 70. The most common type is non-small-cell lung cancer (NSCLC), which grows from the ...

Lung (pulmonary) sarcoma is a rare type of cancer that forms in the blood vessels and supportive tissue in your lungs. Most lung cancers, including small cell and non small cell lung cancers, are ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...